Coronary Disease - PCI
This video presents the management of a complex and infrequently encountered scenario. A sixty-nine-year-old patient had a large pulmonary artery aneurysm extending from the main pulmonary artery (PA) up to the bifurcation with further extension...
In this pre-specified analysis of the EXCEL trial, 1,882 patients with left main disease underwent percutaneous coronary intervention (PCI) (n=952) or coronary artery bypass grafting (CABG) (n=930). At five years,...
The debate continues over long-term outcomes of percutaneous coronary intervention (PCI) vs. coronary artery bypass grafting (CABG) in patients with non-ST-segment elevation myocardial infarction (NSTEMI) and multivessel disease. This study,...
This commentary succinctly reviews the 2021 coronary revascularization and the 2023 chronic coronary disease guidelines with relation to use of PCI and CABG in patients with ischemic cardiomyopathy and ejection...
In a research letter on a small pilot genomic study of sampling coronary atheroma, the authors offer a brief explanation on how their technique can be applied to detect stability...
Head and colleagues used a patient-data pooled analysis of 11 randomized clinical trials to compare stroke rates between surgical and percutaneous coronary revascularization. They found that in the first 30...
Over 1200 patients with stable coronary artery disease and at least one angiographically-significant stenosis were randomized to percutaneous coronary intervention (PCI) plus medical therapy or medical therapy alone for lesions...
The authors present the 5-year follow-up results of the HYBRID trial, wherein 200 patients with multivessel disease requiring revascularization were randomized to either conventional coronary artery bypass grafting (CABG) or...
Filmed at the 2017 EACTS Annual Meeting in Vienna, Austria, Leanne Harling of Imperial College in London, UK, moderates a discussion on the future of coronary revascularization with David Taggart...
Freemantle and colleagues discuss evidence evaluating myocardial revascularization strategies, focusing in particular on conclusions that can and cannot be drawn from subgroup analyses. The authors detail the benefits and limitations...
A few months after its publication, the ORBITA trial results do not seem to have filtered adequately to cardiac multidisciplinary teams worldwide.
...In this patient level meta-analysis of 11 randomised trials, the authors compare PCI using stents with CABG. In total, almost 12,000 randomised patients were included. They found that at a...
A very brief editorial on frailty as a risk factor. In the time of weighing transcatheter interventions versus variable access surgical options, quantifying this physiological concept is of major importance...



